Get the latest Science News and Discoveries

Ibrutinib with rituximab in previously untreated CLL: indication of added benefit over FCR


None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Ibrutinib

Ibrutinib

Photo of FCR

FCR